With this notice, Frontiers states its awareness of serious allegations surrounding the article “Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells” published on 28 January 2016. Our Chief Editors, Prof. Theophile Godfraind and Prof. Olivier Feron, will direct an investigation in full accordance with our procedures. The situation will be updated as soon as the investigation is complete.
Summary
Keywords
Apoptosis, cell cycle arrest, Nickel(II) complex, NF-κB, Colon Cancer
Citation
Frontiers Editorial Office (2016) Expression of Concern: Mechanism of Action of the Novel Nickel(II) Complex in Simultaneous Reactivation of the Apoptotic Signaling Networks Against Human Colon Cancer Cells. Front. Pharmacol. 7:190. doi: 10.3389/fphar.2016.00190
Received
14 June 2016
Accepted
14 June 2016
Published
15 June 2016
Volume
7 - 2016
Edited and reviewed by
Théophile Godfraind, Université Catholique de Louvain, Belgium
Updates
Copyright
© 2016 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office editorial.office@frontiersin.org
This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.